tm logo
E ENDO
Live/Registered
REGISTERED

on 06 Sep 2022

Last Applicant/ Owned by

SIMMONSCOURT ROAD

BALLSBRIDGE

IE

4

Serial Number

88346714 filed on 19th Mar 2019

Registration Number

6839766 registered on 06th Sep 2022

in the Principal Register

Correspondent Address

Camille M. Miller

Camille M. Miller Cozen O'Connor

Suite 2800

Philadelphia, PA 19103

UNITED STATES

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

E ENDO

drug substances, namely, enzymes for medical use applied by injection available only via prescription; pharmaceutical preparations for the treatment of cellulite applied by injection and available only via prescription

Classification Information


Class [005]
Pharmaceutical Products


drug substances, namely, enzymes for medical use applied by injection available only via prescription; pharmaceutical preparations for the treatment of cellulite applied by injection and available only via prescription


First Use Date in General

06th Jul 2020

First Use Date in Commerce

06th Jul 2020

Mark Details


Serial Number

No 88346714

Mark Type

No Service/Collective Mark

Attorney Docket Number

No ENDO1170US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.01.21 -

Circles that are totally or partially shaded

26.17.09 -

Curved line(s), band(s) or bar(s)

27.03.01 -

Geometric figures forming letters or numerals, including punctuation

Legal History


Show more

Status DateAction Taken
28th Jun 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
01st May 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06th Sep 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
06th Sep 2022REGISTERED-PRINCIPAL REGISTER
30th Jul 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
29th Jul 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
14th Jul 2022STATEMENT OF USE PROCESSING COMPLETE
08th Jul 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
16th Jun 2022USE AMENDMENT FILED
16th Jun 2022TEAS STATEMENT OF USE RECEIVED